View our story

CHX Technologies has developed a first-in-class drug, Prevora, which protects high-risk adults from the bacteria causing dental decay.

Prevora serves one of the largest unmet needs in healthcare. 2 of 3 adults over age 50 are at high-risk of ongoing cavities, crowns, root canals and extractions.  

This new medication is safe, painless and is applied topically by dental and medical professionals. Prevora’s impact is better oral health at lower cost.

In 2017, CHX will file Prevora’s New Drug Application to the FDA. CHX will also then begin marketing Prevora in Canada and the UK via strategic partners.

Powered by